341 related articles for article (PubMed ID: 11078210)
21. Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism.
Hasselgren PO
Mol Biol Rep; 1999 Apr; 26(1-2):71-6. PubMed ID: 10363650
[TBL] [Abstract][Full Text] [Related]
22. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
[TBL] [Abstract][Full Text] [Related]
23. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
[TBL] [Abstract][Full Text] [Related]
24. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
Mizuno Y; Nonaka I; Hirai S; Ozawa E
J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
[TBL] [Abstract][Full Text] [Related]
26. Dystrophin-related protein in skeletal muscles in neuromuscular disorders: immunohistochemical study.
Takemitsu M; Nonaka I; Sugita H
Acta Neuropathol; 1993; 85(3):256-9. PubMed ID: 8460531
[TBL] [Abstract][Full Text] [Related]
27. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
Wang S; Shen D
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
[TBL] [Abstract][Full Text] [Related]
28. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Charan RA; Hanson R; Clemens PR
FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
[TBL] [Abstract][Full Text] [Related]
29. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
30. Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study.
Batra A; Lott DJ; Willcocks R; Forbes SC; Triplett W; Dastgir J; Yun P; Reghan Foley A; Bönnemann CG; Vandenborne K; Walter GA
J Neuromuscul Dis; 2020; 7(4):407-417. PubMed ID: 32538860
[TBL] [Abstract][Full Text] [Related]
31. Distribution of ten laminin chains in dystrophic and regenerating muscles.
Patton BL; Connoll AM; Martin PT; Cunningham JM; Mehta S; Pestronk A; Miner JH; Sanes JR
Neuromuscul Disord; 1999 Oct; 9(6-7):423-33. PubMed ID: 10545049
[TBL] [Abstract][Full Text] [Related]
32. Reduced expression of aquaporin 4 in human muscles with amyotrophic lateral sclerosis and other neurogenic atrophies.
Jimi T; Wakayama Y; Matsuzaki Y; Hara H; Inoue M; Shibuya S
Pathol Res Pract; 2004; 200(3):203-9. PubMed ID: 15200272
[TBL] [Abstract][Full Text] [Related]
33. Dystrophin expression in skin biopsy immunohistochemical. Localisation of striated muscle type dystrophin.
Marbini A; Marcello N; Bellanova MF; Guidetti D; Ferrari A; Gemignani F
J Neurol Sci; 1995 Mar; 129(1):29-33. PubMed ID: 7751841
[TBL] [Abstract][Full Text] [Related]
34. Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle.
Farini A; Sitzia C; Cassinelli L; Colleoni F; Parolini D; Giovanella U; Maciotta S; Colombo A; Meregalli M; Torrente Y
Development; 2016 Feb; 143(4):658-69. PubMed ID: 26884398
[TBL] [Abstract][Full Text] [Related]
35. [Expression of connective tissue growth factor in progressive muscular dystrophy].
Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
[TBL] [Abstract][Full Text] [Related]
36. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
Vainzof M; Pavanello RC; Pavanello Filho I; Passos-Bueno MR; Rapaport D; Hsi CT; Zatz M
J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
[TBL] [Abstract][Full Text] [Related]
37. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H
Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
[TBL] [Abstract][Full Text] [Related]
38. Decorin and biglycan expression is differentially altered in several muscular dystrophies.
Zanotti S; Negri T; Cappelletti C; Bernasconi P; Canioni E; Di Blasi C; Pegoraro E; Angelini C; Ciscato P; Prelle A; Mantegazza R; Morandi L; Mora M
Brain; 2005 Nov; 128(Pt 11):2546-55. PubMed ID: 16183658
[TBL] [Abstract][Full Text] [Related]
39. Functional significance of dystrophin-positive fibers in Duchenne and Becker muscular dystrophy.
Taşdemir HA; Kotiloğlu E; Topaloğlu H; Kale G; Dinçer DP; Yalaz K; Renda Y
Pediatr Pathol Lab Med; 1996; 16(4):583-90. PubMed ID: 9025855
[TBL] [Abstract][Full Text] [Related]
40. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy.
Monici MC; Aguennouz M; Mazzeo A; Messina C; Vita G
Neurology; 2003 Mar; 60(6):993-7. PubMed ID: 12654966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
